Savant Capital LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 71.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,062 shares of the medical instruments supplier’s stock after acquiring an additional 34,750 shares during the quarter. Savant Capital LLC’s holdings in DENTSPLY SIRONA were worth $1,577,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Canvas Wealth Advisors LLC lifted its stake in DENTSPLY SIRONA by 126.5% in the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after acquiring an additional 182,234 shares during the period. Entropy Technologies LP purchased a new stake in DENTSPLY SIRONA in the fourth quarter worth $630,000. Choreo LLC lifted its stake in DENTSPLY SIRONA by 191.6% in the fourth quarter. Choreo LLC now owns 23,507 shares of the medical instruments supplier’s stock worth $440,000 after acquiring an additional 15,446 shares during the period. OLD National Bancorp IN lifted its stake in DENTSPLY SIRONA by 45.3% in the fourth quarter. OLD National Bancorp IN now owns 18,874 shares of the medical instruments supplier’s stock worth $358,000 after acquiring an additional 5,884 shares during the period. Finally, Pacer Advisors Inc. lifted its stake in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.
Analysts Set New Price Targets
XRAY has been the subject of a number of research analyst reports. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Needham & Company LLC reissued a “buy” rating and set a $25.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Finally, Barrington Research lowered their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Nine analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus target price of $26.33.
DENTSPLY SIRONA Price Performance
XRAY opened at $18.77 on Friday. The stock has a 50-day moving average price of $19.04 and a 200-day moving average price of $22.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.73 billion, a PE ratio of -9.07, a P/E/G ratio of 1.83 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $34.91.
DENTSPLY SIRONA Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. The ex-dividend date was Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.41%. DENTSPLY SIRONA’s payout ratio is -30.92%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- How to Plot Fibonacci Price Inflection Levels
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- What is Insider Trading? What You Can Learn from Insider Trading
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Overbought Stocks Explained: Should You Trade Them?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.